"Breast Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the human BREAST.
Descriptor ID |
D001943
|
MeSH Number(s) |
C04.588.180 C17.800.090.500
|
Concept/Terms |
Breast Neoplasms- Breast Neoplasms
- Breast Neoplasm
- Neoplasm, Breast
- Breast Tumors
- Breast Tumor
- Tumor, Breast
- Tumors, Breast
- Neoplasms, Breast
Breast Carcinoma- Breast Carcinoma
- Breast Carcinomas
- Carcinoma, Breast
- Carcinomas, Breast
Mammary Neoplasms, Human- Mammary Neoplasms, Human
- Human Mammary Neoplasm
- Human Mammary Neoplasms
- Neoplasm, Human Mammary
- Neoplasms, Human Mammary
- Mammary Neoplasm, Human
Breast Cancer- Breast Cancer
- Cancer, Breast
- Mammary Cancer
- Cancer, Mammary
- Cancers, Mammary
- Mammary Cancers
- Malignant Neoplasm of Breast
- Breast Malignant Neoplasm
- Breast Malignant Neoplasms
- Malignant Tumor of Breast
- Breast Malignant Tumor
- Breast Malignant Tumors
- Cancer of Breast
- Cancer of the Breast
|
Below are MeSH descriptors whose meaning is more general than "Breast Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Breast Neoplasms".
This graph shows the total number of publications written about "Breast Neoplasms" by people in this website by year, and whether "Breast Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 79 | 9 | 88 |
1995 | 54 | 12 | 66 |
1996 | 81 | 13 | 94 |
1997 | 109 | 21 | 130 |
1998 | 116 | 23 | 139 |
1999 | 130 | 21 | 151 |
2000 | 118 | 29 | 147 |
2001 | 140 | 14 | 154 |
2002 | 120 | 17 | 137 |
2003 | 206 | 37 | 243 |
2004 | 221 | 37 | 258 |
2005 | 274 | 40 | 314 |
2006 | 259 | 36 | 295 |
2007 | 244 | 22 | 266 |
2008 | 246 | 31 | 277 |
2009 | 267 | 51 | 318 |
2010 | 327 | 51 | 378 |
2011 | 326 | 44 | 370 |
2012 | 310 | 44 | 354 |
2013 | 278 | 43 | 321 |
2014 | 302 | 36 | 338 |
2015 | 286 | 25 | 311 |
2016 | 248 | 29 | 277 |
2017 | 236 | 24 | 260 |
2018 | 257 | 28 | 285 |
2019 | 252 | 27 | 279 |
2020 | 249 | 19 | 268 |
2021 | 271 | 13 | 284 |
2022 | 226 | 1 | 227 |
2023 | 215 | 2 | 217 |
2024 | 49 | 0 | 49 |
To return to the timeline,
click here.
Below are the most recent publications written about "Breast Neoplasms" by people in Profiles.
-
Neutrophil Elastase Remodels Mammary Tumors to Facilitate Lung Metastasis. Mol Cancer Ther. 2024 Apr 02; 23(4):492-506.
-
The Power and Promise of Patient-Derived Xenografts of Human Breast Cancer. Cold Spring Harb Perspect Med. 2024 Apr 01; 14(4).
-
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clin Cancer Res. 2024 Apr 01; 30(7):1273-1280.
-
When and how to discuss about palliative care and advance care planning with cancer patients: A mixed-methods study. Palliat Support Care. 2024 Apr; 22(2):387-395.
-
Breast Radiologists' Perceptions on the Detection and Management of Invasive Lobular Carcinoma: Most Agree Imaging Beyond Mammography Is Warranted. J Breast Imaging. 2024 Apr 01; 6(2):157-165.
-
Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the dose expansion groups of an open-label, phase 1b study. Lancet Oncol. 2024 Apr; 25(4):474-487.
-
Multimodality Imaging of Benign and Malignant Diseases of the Nipple-Areolar Complex. Radiographics. 2024 Apr; 44(4):e230113.
-
Premastectomy Radiotherapy and Immediate Breast Reconstruction: A Randomized Clinical Trial. JAMA Netw Open. 2024 Apr 01; 7(4):e245217.
-
Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial. Nat Commun. 2024 Mar 19; 15(1):2446.
-
Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II-III breast cancer. Oncotarget. 2024 Mar 19; 15:238-247.